SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Cervarix: Food and Drug Administration

By

Proper Name: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant Tradename: Cervarix Manufacturer: GlaxoSmithKline Biologicals 16 October 2009, Cervarix® was approved for use in the United States, by the FDA. To examine all available FDA documents pertaining to the approval of this HPV vaccine visit the two FDA links below. Proper Name: Human Papillomavirus […]

PRESCRIBING INFORMATION FOR CERVARIX

By

INDICATIONS AND USAGE  CERVARIX® is indicated for the prevention of the following diseases caused by oncogenic human papillomavirus (HPV) types 16 and 18 [see Clinical Studies (14)]: Cervical cancer Cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and Cervical intraepithelial neoplasia (CIN) grade 1. CERVARIX is approved for use in females […]

Physicians Avoid Recommending HPV Vaccine in Girls Aged 11 to 12 Years

By

By:  Fran Lowry From Medscape Medical News August 4, 2010 — The majority of pediatricians and family physicians in the United States are offering the human papillomavirus (HPV) vaccine to their older adolescent patients, but fewer are recommending the vaccine to their younger patients (those aged 11 to 12 years) — the age group that […]

News

Videos

Contact